GeneReach Biotechnology Corporation


By developing, manufacturing and marketing products for applied nucleic acid detection technology, GeneReach Biotechnology provides pathogen detection platforms to multiple industries and have introduced them into human health industries.

POCKIT® Central SARS-CoV-2 (orf 1ab) Premix Reagent is an CE-marked in vitro diagnostic molecular assay for qualitative detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) RNA in oro/nasopharyngeal swabs from patients suspected of SARS-CoV-2 infection. This assay is intended for use with POCKIT® Central system.
Application areas
  1. For use with POCKIT Central Nucleic Acid Analyzer
  2. In vitro diagnostic use
  3. Professional use
  1. Clinical performance is equivalent to real-time PCR
  2. Easy-to-use, no sample pretreatment
  3. Process up to 8 samples in 85 minutes
  4. Detect prevailing SARS-CoV-2 variants (VOC & VOI)

The company offers OEM/ODM for LDTs and service provider of PCR reagent lyophilization.